BMS-214662
BMS-214662 Uses, Dosage, Side Effects, Food Interaction and all others data.
BMS-214662 has been used in trials studying the treatment of Childhood Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Recurrent Adult Acute Myeloid Leukemia, Relapsing Chronic Myelogenous Leukemia, and Adult Acute Promyelocytic Leukemia (M3), among others.
| Trade Name | BMS-214662 |
| Generic | BMS-214662 |
| Type | |
| Formula | C25H23N5O2S2 |
| Weight | Average: 489.612 Monoisotopic: 489.129316385 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here BMS-214662
